-
MEDNAX To Sell MEDNAX Radiology Solutions To Radiology Partners For $885M
Post on 9/10/20
-
Is Pfizer the Best Way to Play the Coronavirus Vaccine Race?
Post on 9/10/20
-
Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU
Post on 9/10/20
-
Seelos Therapeutics Closes $7M Registered Direct Offering
Post on 9/9/20
-
Feinstein Institutes Receives $1.7M Grant
Post on 9/9/20
-
Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million
Post on 9/9/20
-
Ambu Awarded Contract with UroGPO for Single-Use Cystoscope
Post on 9/8/20
-
Gardner Standard Partners with Wisconsin Pharmacal Company
Post on 9/8/20
-
Feinstein Institutes Receives $1.7M NIH Grant
Post on 9/8/20
-
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political Pressure
Post on 9/8/20
-
Johnson & Johnson Aiming to Enroll One-Third of Phase 3 Trial Patients From Latin America
Post on 9/8/20
-
Is Vertex Pharmaceuticals Stock a Buy?
Post on 9/8/20
-
Royalty Pharma Closes $6B Senior Unsecured Notes
Post on 9/5/20
-
Seelos Therapeutics Pricing of $7.0 Million Registered Direct Offering
Post on 9/4/20
-
Better Coronavirus Stock: AstraZeneca or Johnson & Johnson?
Post on 9/4/20
-
Pfizer CEO Expects Pivotal Coronavirus Vaccine Data in October
Post on 9/4/20
-
Johnson & Johnson Coronavirus Vaccine Candidate Shows Encouraging Results in Animal Trial
Post on 9/4/20
-
PRA Health Sciences Partnership with The Leukemia & Lymphoma Society
Post on 9/3/20
-
Northwell Labs Invests $30M
Post on 9/3/20
-
Why These 3 Coronavirus Stocks Are Falling This Week
Post on 9/3/20
-
Pfizer Has Been a Mediocre Stock at Best. Here's Why You Should Consider Buying It Anyway
Post on 9/3/20
-
JMD Properties Acquires Diagnostic Oncology Company
Post on 9/2/20
-
Celsion Corp. Restructures its Strategic Loan Facility
Post on 9/2/20
-
Forget Johnson & Johnson, AbbVie Is a Better Dividend Stock
Post on 9/2/20
-
CityMD Acquires Urgent Care Now
Post on 9/1/20
New York
